(2) Activated PLC may then hydrolyze membrane phosphatidylinositol 4,5-bisphosphate (PIP) into inositol 1,4,5-trisphosphate (IP) and diacylglycerol (DAG)
Appetite Regulation At the core of this therapy, GLP-1 receptor agonists decrease appetite by acting on hunger centers within the brain
Weight loss journeys dont end with GLP-1s The GLP-1 journey does not end when the prescription stops
Unlike GLP-1 agonists that work primarily through incretin pathways, cagrilintide provides complementary satiety signaling through amylin receptors in the area postrema (AP) and nucleus tractus solitarius (NTS) of the brainstem
Every weight loss journey is different
Work with your naturopathic physician to optimize nutrition, establish exercise habits and address gut health, creating a foundation for successful peptide therapy when appropriate options become available